Menu Search
Equities

Memscap SA

0NYT:LSE

Memscap SA

Actions
  • Price (EUR)4.46
  • Today's Change0.26 / 6.19%
  • Shares traded930.00
  • 1 Year change-12.89%
  • Beta--
Data delayed at least 20 minutes, as of Sep 27 2024 15:36 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Memscap SA is a France-based company engaged in the provision of solutions based on micro-electromechanical systems (MEMS) technology. The Company operates in three market segments-standard products: integrate the design and manufacturing of sensors and multifunctional measurement systems intended for the medical, biomedical, aeronautical and defense industries; custom products: include the design and manufacturing of MEMS components, licensing of intellectual property as well as customer cooperation projects for custom development and production; and dermo-cosmetics division: integrates the operation and management of the group's assets relating to the dermatology and cosmetology sectors, including in particular the Ioma brand.. The Company's products include pressure sensors, pressure transducers, pressure switches, medical accessories, optical attenuators (chips), micro relays and Multi-User MEMS Processes, such as PolyMUMPs, SOIMUMPs, MetalMUMPs, and PiezoMUMPs.

  • Revenue in EUR (TTM)14.26m
  • Net income in EUR2.00m
  • Incorporated1997
  • Employees69.00
  • Location
    Memscap SAParc Activillage des FontainesZI Bernin, Crolles CedexCROLLES 38926FranceFRA
  • Phone+33 476928500
  • Fax+33 476928510
  • Websitehttps://memscap.com/en
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.